A new study examines tools that pharma companies use to keep drug prices high an...
It isn't just obesity — chronic liver disease is also an increasing problem in t...
Medical marijuana companies sell medicine, just like pharma companies. But a STA...
As STAT looks back at 2023 in photographs, the faces of so many stand out.
Why haven’t health care cost increases exceeded inflation in recent years? There...
Congress gave the FDA more power to get companies to racially diversify clinical...
“Those two caricatures that they put on national TV is how people view us,” an a...
The Securities and Exchange Commission charged Laura Perryman, former CEO of med...
Understand how science, health policy, and medicine shape the world everyday. Si...
Want to stay on top of the science and politics driving biotech today? Sign up t...
A German court invalidated a patent at the center of a CureVac lawsuit against B...
Argenx said Wednesday that its closely watched therapy failed to outperform plac...
After two years of steady decline in biotech, industry optimists might be onto s...
The U.S. must raise federal alcohol taxes to address the alarming rise in alcoho...
MABS-139 is under clinical development by Manhattan Biosolutions and currently i...
FLU-SV-mRNA is under clinical development by Curevac and currently in Phase I fo...